Genetic Technologies Announces U.S. Patent Office Allows First Patent for ImmunAid
July 10, 2013 05:15 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Jul 10, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that ImmunAid Limited, in which GTG holds a 45% direct equity...
Genetic Technologies Announces Record Number of BREVAGen(TM) Tests
July 01, 2013 07:00 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Jul 1, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announces that a record number of BREVAGen™ test samples were received during the...
Genetic Technologies Settles Its Dispute With Ingelheim, Germany-Based Bioscientia Institute for Medical Diagnostics
June 24, 2013 05:15 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Jun 24, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that it has now settled its dispute with Bioscientia Institute for...
Genetic Technologies Announces Independent Clinical Validation Study in Support of the Utilization of BREVAGen(TM)
June 24, 2013 05:15 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Jun 24, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announces the publication online in Breast Cancer Research & Treatment on Friday,...
Genetic Technologies Executes Agreement With Further Nationwide Provider Network for BREVAGen(TM)
June 19, 2013 05:15 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Jun 19, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that through its wholly-owned subsidiary Phenogen Sciences Inc. it...
Genetic Technologies Provides U.S. Gene Patenting Update
June 17, 2013 08:00 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Jun 17, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) provides an update to the Market on its position following the U.S. Supreme Court's...
Alchemia Limited Provides Company Update
May 22, 2013 06:00 ET
|
Alchemia
BRISBANE, AUSTRALIA--(Marketwired - May 22, 2013) -
$2.4M fondaparinux profit share recorded for quarter ending 31 March 2013
Establishment of a...
Genetic Technologies Executes Agreement With MultiPlan, Inc., a Nationwide Provider Network
May 20, 2013 06:00 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - May 20, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that, through its wholly-owned subsidiary Phenogen Sciences Inc.,...
Vital Therapies, Inc. Adds Two New Board Members
May 16, 2013 06:00 ET
|
Vital Therapies
SAN DIEGO, CA--(Marketwired - May 16, 2013) - Vital Therapies, Inc., a development stage biotechnology company focused on developing the first bio-artificial liver for life-threatening acute liver...
Sunshine Heart, Inc. gibt in europäischer Studie für Anwendungsbeobachtung die erste Implantation des 'C-Pulse-System' bekannt
May 09, 2013 17:14 ET
|
Sunshine Heart
EDEN PRAIRIE, MN--(Marketwired - May 9, 2013) -
Sunshine Heart, Inc. (NASDAQ: SSH) hat heute in einer multizentrischen Studie die erste Implantation des OPTIONS HF C-Pulse System bekannt gegeben....